Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to sever active ulcerative colitis | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to sever active ulcerative colitis

Implementing Organization

All India Institute of Medical Sciences

Principal Investigator

Dr Vineet Ahuja

Professor

|

All India Institute of Medical Sciences

Related Research

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Gastroenterology

Start Year

2017

End Year

2020

Sanction Amount

₹ 10.00 L

Status

Completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

N/A

Startup (If Any)

00

No. of Patents

Filed :00

Grant :00